Close

GTS3/4

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

There are four serotypes of DENV (DENV1–DENV4), which differ at the amino-acid level by 30–35%. As a consequence of this heterogeneity, immunity to one serotype does not necessarily protect against infection with another serotype. Sequential infections are therefore common in DENV-endemic countries, where all four serotypes often circulate at the same time or replace each other in a cyclical manner. Epidemiological studies have further shown that adverse clinical outcomes are more frequent during secondary or recurrent infections.
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0521 Human anti-GTS3/4 T cell receptor (D2H), pCDTCR1 DENV3 D2H Human GTSGSPIINR HLA-A*11:01 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0522 Human anti-GTS3/4 T cell receptor (D30), pCDTCR1 DENV3 D30 Human GTSGSPIINR HLA-A*11:01 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.